155 related articles for article (PubMed ID: 20298294)
1. 18F-fluoro-deoxyglucose PET for monitoring treatment in sarcoidosis.
Mortensen J; Loft A; Baslund B
Clin Respir J; 2007 Dec; 1(2):124-6. PubMed ID: 20298294
[No Abstract] [Full Text] [Related]
2. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
[TBL] [Abstract][Full Text] [Related]
3. Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy.
Aide N; Benayoun M; Kerrou K; Khalil A; Cadranel J; Talbot JN
Br J Radiol; 2007 Mar; 80(951):e67-71. PubMed ID: 17548505
[TBL] [Abstract][Full Text] [Related]
4. Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis.
Ishimaru S; Tsujino I; Sakaue S; Oyama N; Takei T; Tsukamoto E; Tamaki N; Nishimura M
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):234-5. PubMed ID: 16315788
[No Abstract] [Full Text] [Related]
5. [Active cardiac sarcoidosis: Diagnosis and adjustment of therapy with FDG PET/CT].
Philippe L; Casset-Senon D; Lorette G; Diot P; Cosnay P
Presse Med; 2015 Jun; 44(6 Pt 1):690-2. PubMed ID: 25534464
[No Abstract] [Full Text] [Related]
6. Left ventricular asynchrony in early isolated cardiac sarcoidosis.
Nagai T; Arakawa J; Fujikawa A; Kastushika S
Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):40. PubMed ID: 26578651
[No Abstract] [Full Text] [Related]
7. Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques.
Pandya C; Brunken RC; Tchou P; Schoenhagen P; Culver DA
Eur Respir J; 2007 Feb; 29(2):418-22. PubMed ID: 17264327
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and monitoring of cardiac sarcoidosis with delayed-enhanced MRI and 18F-FDG PET-CT.
Matthews R; Bench T; Meng H; Franceschi D; Relan N; Brown DL
J Nucl Cardiol; 2012 Aug; 19(4):807-10. PubMed ID: 22466988
[No Abstract] [Full Text] [Related]
9. Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.
Milman N; Graudal N; Loft A; Mortensen J; Larsen J; Baslund B
Clin Respir J; 2012 Oct; 6(4):238-47. PubMed ID: 22128762
[TBL] [Abstract][Full Text] [Related]
10. Relevance of concurrent hypercalcemia in ureteric sarcoidosis complicated with bladder urothelial carcinoma: a case report.
Hayashida M; Yano A; Hagiwara K; Nagamoto S; Ogawa K; Sakaguchi K; Sawa N; Okaneya T; Urakami S
BMC Nephrol; 2020 Jun; 21(1):235. PubMed ID: 32571234
[TBL] [Abstract][Full Text] [Related]
11. Uncommon extent involvement of sarcoidosis in 18F-FDG PET/CT.
Küçük NO; Ozkan E; Aras G
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2151. PubMed ID: 17874096
[No Abstract] [Full Text] [Related]
12. The role of positron emission tomography-computed tomography/magnetic resonance imaging in the management of sarcoidosis patients.
Promteangtrong C; Salavati A; Cheng G; Torigian DA; Alavi A
Hell J Nucl Med; 2014; 17(2):123-35. PubMed ID: 25097898
[TBL] [Abstract][Full Text] [Related]
13. Does 18F-fluorodeoxyglucose PET/CT have a role in the management of pulmonary and extra pulmonary sarcoidosis?
Carbone R; Douroukas A; Arena V; Cantalupi D; Balleari E; Ghio R; Pelosi E
Monaldi Arch Chest Dis; 2008 Jun; 69(2):81-2. PubMed ID: 18837423
[No Abstract] [Full Text] [Related]
14. Follow-up of muscular sarcoidosis using fluorodeoxyglucose positron emission tomography.
Marie I; Lahaxe L; Vera P; Edet-Samson A
QJM; 2010 Dec; 103(12):1000-2. PubMed ID: 20385567
[No Abstract] [Full Text] [Related]
15. [Application of fluorine-18 fluorodeoxyglucose-positron emission tomography in the diagnosis and therapy of patients with sarcoidosis].
Li D; Lü PX
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):447-50. PubMed ID: 24103209
[No Abstract] [Full Text] [Related]
16. Fluorodeoxyglucose positron emission tomography/computed tomography for diagnostic imaging in relapsing polychondritis with atypical manifestations.
Honne K; Nagashima T; Onishi S; Nagatani K; Iwamoto M; Minota S
J Clin Rheumatol; 2013 Mar; 19(2):104-5. PubMed ID: 23425669
[No Abstract] [Full Text] [Related]
17. Clinical utility of a magnetic resonance-conditional pacemaker in a patient with cardiac sarcoidosis.
Ishibashi K; Takeda M; Yamahara Y
Intern Med; 2013; 52(12):1341-5. PubMed ID: 23774544
[TBL] [Abstract][Full Text] [Related]
18. Sarcoidosis mimicking metastatic breast cancer on FDG PET/CT.
Zivin S; David O; Lu Y
Intern Med; 2014; 53(21):2555-6. PubMed ID: 25366024
[No Abstract] [Full Text] [Related]
19. Advanced imaging of cardiac sarcoidosis.
Schatka I; Bengel FM
J Nucl Med; 2014 Jan; 55(1):99-106. PubMed ID: 24232870
[TBL] [Abstract][Full Text] [Related]
20. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
Treglia G; Annunziata S; Sobic-Saranovic D; Bertagna F; Caldarella C; Giovanella L
Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
